{"name":"Elixirgen Therapeutics, Inc.","slug":"elixirgen-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"Elixirgen Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies. The company's lead candidate, EXG34217, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTFAyZWNtY1RHQnZjYW9EZHc4RHRXLVlWd2pTNTBFRC1iM2dFaXBGQlFSNjNPZVQ4WnBSYTVXVGYydGF6WnlkRHVMVmtEZzJZbHFpb2E4NlE5QktFdHhwQ2JHYjhiYUJvaTRuZnJ3?oc=5","date":"2026-03-18","type":"pipeline","source":"Labiotech.eu","summary":"Maryland’s hottest biotech startups in 2026 - Labiotech.eu","headline":"Maryland’s hottest biotech startups in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNc0REd0xraWFiYTJfLVdfWHNSb0JsWTJjNnV3bzg4aHA1d2VKN3JjdnBQR0NXM3Z2aUJEMWlXbEpMSHF3Tjd1Qmwtel95SWVDSFRMTFl3NFk3b2l3OTBILXhRc0NyUUJjakYyRGhHX25zdXdwdzl2U21sZ0NzTmhnNTRVTWxpQjg1cFJmd2ZUSmNHNHZlVWVDYVF4T0hBZzUzbGc?oc=5","date":"2025-11-17","type":"pipeline","source":"Research Horizons","summary":"A Bold Investment to Make the Future of Medicine Happen - Research Horizons","headline":"A Bold Investment to Make the Future of Medicine Happen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNb0FBX2RHMkdNVEhRY0FBdDhZaWZHYmN2NmVwc29xYzdtT0pkcldCamtSY1pXRWFvWjNxU0JJRHhxaVZnajVhWU5RaEJjWmhCQndsQzhjTzVPZ2lJT0JlRjRaeHpqMEJYZTFTaU0tV1NzZWVNM1J6RFBWSE5LNS1pcjRldTEzQk8wNFI3MU9IMUxkZmot?oc=5","date":"2025-05-05","type":"pipeline","source":"Drug Discovery News","summary":"Gene therapy offers new hope for telomere diseases - Drug Discovery News","headline":"Gene therapy offers new hope for telomere diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxON1RKTWJYaGYtQW1LUmR4a2NSZEtVMFhnOXNRRkZLakg4QjVISXYwalNlQTRMUl9rbGNQblI2RG9PMV9pb1ljYktnVXpNV1hDWGhSaVQzcWQwWTNUWFFGZFJrVG1TSExOS0JwR1ZRM05jcm5uVTZpUGhCY3JYTTF1OXNZOXVwMmxWTGthTlE3WXpsOVl4U2V3UmxjN1JfTVNaTDZoNHRWRHZudnE5Smc?oc=5","date":"2025-02-26","type":"trial","source":"Clinical Trials Arena","summary":"Elixirgen’s gene therapy shows promise in telomere biology disorders - Clinical Trials Arena","headline":"Elixirgen’s gene therapy shows promise in telomere biology disorders","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}